Christine Schneider Data-verified

OverviewAI-generated summary

Christine Schneider's research focuses on neurological disorders, particularly Parkinson's disease and conditions that mimic its symptoms, such as progressive supranuclear palsy. Her work investigates the relationship between brain structure, function, and cognitive impairment. Recent publications explore the use of neuroimaging techniques, like 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET), to differentiate between various neurodegenerative diseases and predict cognitive decline. Schneider also studies the predictive value of "brain age" – a measure derived from neuroimaging – for cognitive impairment in Parkinson's disease patients.

Beyond neuroimaging, her research extends to other areas of human health and biology. This includes investigating the role of specific metabolites, such as Trimethylamine-N-Oxide (TMAO), in cerebrovascular atherosclerosis. Additionally, she has published on the applications of engineered bacteriophages and has explored the effects of transcranial direct current stimulation (tDCS) on working memory. Her scholarly output is marked by a significant number of publications and citations, reflected in her h-index of 30 and a total of 5,322 citations.

Metrics

• h-index: 30
• Publications: 106
• Citations: 5,333